Bioresta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 27,396 | 21,718 | 6,255 | 96,950 | 46,389 | 40,667 | 81,454 | 128,135 |
| Profit before tax | 5,538 | -1,690 | -3,806 | 214 | -1,293 | 3,159 | 12,866 | 8,265 |
| Net profit | 5,264 | -1,690 | -3,806 | 214 | -1,293 | 3,159 | 12,115 | 7,769 |
| Equity | 8,307 | 6,358 | 2,371 | 2,585 | 1,291 | 4,451 | 16,565 | 24,335 |
| Liabilities | 2,889 | 11,308 | 7,545 | 9,119 | 10,236 | 11,728 | 10,361 | 23,253 |
| Non-current assets | 1,213 | 0 | 0 | 0 | 0 | 547 | 335 | 123 |
| Current assets | 9,983 | 17,418 | 9,731 | 11,492 | 11,959 | 15,776 | 32,980 | 48,139 |
| Total assets | 11,196 | 17,418 | 9,731 | 11,492 | 11,959 | 16,323 | 33,315 | 48,262 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 6,552 | 13,913 | 22,660 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +56.6% | -20.7% | -71.2% | +1450.0% | -52.2% | -12.3% | +100.3% | +57.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 47.0% | -9.7% | -39.1% | 1.9% | -10.8% | 19.4% | 36.4% | 16.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 63.4% | -26.6% | -160.5% | 8.3% | -100.2% | 71.0% | 73.1% | 31.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 19.2% | -7.8% | -60.8% | 0.2% | -2.8% | 7.8% | 14.9% | 6.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 20.2% | -7.8% | -60.8% | 0.2% | -2.8% | 7.8% | 15.8% | 6.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 1.8 | 3.2 | 3.5 | 7.9 | 2.6 | 0.6 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 27,396 | 21,718 | 6,255 | 96,950 | 46,389 | 40,667 | 81,454 | 128,135 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioresta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-01-16 | 2025-01-16 | 199.17 |
| 2024-11-18 | 2024-12-12 | 1.35 |
| 2024-10-24 | 2024-11-10 | 1.35 |
| 2024-10-16 | 2024-10-23 | 0.70 |
| 2024-09-23 | 2024-10-13 | 0.70 |
| 2024-09-17 | 2024-09-22 | 201.11 |
| 2024-07-24 | 2024-09-16 | 0.70 |
| 2024-07-16 | 2024-07-16 | 200.41 |
| 2024-06-18 | 2024-06-26 | 199.95 |
| 2024-04-16 | 2024-04-16 | 199.77 |
| 2023-08-17 | 2023-10-15 | 0.66 |
| 2023-07-26 | 2023-08-15 | 0.66 |
| 2023-07-24 | 2023-07-25 | 0.67 |
| 2023-07-18 | 2023-07-23 | 0.18 |
| 2023-06-21 | 2023-07-16 | 0.18 |
| 2023-06-16 | 2023-06-20 | 182.72 |
| 2023-05-18 | 2023-06-15 | 0.18 |
| 2023-05-16 | 2023-05-17 | 182.72 |
| 2023-05-04 | 2023-05-15 | 0.18 |
| 2023-04-25 | 2023-04-25 | 0.18 |
| 2023-02-17 | 2023-02-20 | 22.18 |
| 2023-01-17 | 2023-01-18 | 157.78 |
| 2022-12-16 | 2022-12-18 | 157.78 |
| 2022-05-17 | 2022-05-17 | 157.50 |
| 2021-11-16 | 2021-12-13 | 1.55 |
| 2021-10-18 | 2021-10-24 | 140.14 |
Bioresta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-13 | 2025-07-20 | 737.42 |
| 2025-07-02 | 2025-07-20 | 87.48 |
| 2025-04-14 | 2025-04-14 | 261.33 |
| 2025-04-12 | 2025-04-13 | 260.56 |
| 2025-04-09 | 2025-04-11 | 259.53 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioresta, UAB (code 304256854) is a Private Limited Liability Company operating in retail sale of hardware, building materials, paints and glass. In 2025, the company generated revenue of €128.1K, up from €81.5K in 2024 and €40.7K in 2023, showing a strong three-year expansion. Net profit was €7.8K in 2025, compared with €12.1K in 2024 and €3.2K in 2023. Profitability improved sharply in 2024, when the net margin reached 14.9%, before easing to 6.1% in 2025 as sales continued to grow. The balance sheet also expanded: total assets rose to €48.3K in 2025 from €33.3K a year earlier and €16.3K in 2023. Equity increased to €24.3K, while liabilities reached €23.3K, leaving the equity ratio at 50.4% and debt-to-equity at 0.96. Asset turnover stood at 2.65x in 2025, and revenue per employee was €128.1K, indicating solid operating productivity.